Alpha galactosidase in leucocytes
Material: | 6 ml EDTA-blood Dispatch on the same day |
Methods: | Spektrometrie → UV- / VIS-Photometrie | Reference range | 14,0 nmol/h/mg – 72,6 nmol/h/mg |
Indication | Suspicion of Fabry’s disease |
Please note | Fabry’s disease is a sphingolipid storage disorder, caused by alpha galactosidase deficiency. Incidence is 1:40.000, pattern of inheritance is technically X-chromosomal recessive, however due to accidental X-inactivation in individual cells, women may also be affected, however usually with a milder course of illness. Painful neuropathy (palms, soles, “appendicitis”, “renal colic”) in young men, furthermore angiokeratoma (trunk, perineal region) and hypohidrosis. Life expectancy in untreated patients is limited (on average 55 years in men and 70 years in women). Limiting factors are mainly nephrological and cardiovascular complications (progressive kidney failure, cardiomyopathy arrhythmia, cerebral seizure). In men, the evaluation of alpha galactosidase in leukocytes is decisive in diagnostics (enzyme activity usually < 1 % of the norm). In up to one third of women however, normal enzyme activity is seen, hence why sequencing of the GLA gene is definitely required. |
External services | ja Medizinisches Labor Bremen |
More Results for the letter A
- Alpha-1 antitrypsin in the serum, phenotyping (A1APT)
- Alpha-1 antitrypsin, genotyping (A1AGEN)
- Alpha-1 microglobulin in the serum (A1M)
- Alpha-1 microglobulin in the urine (A1MGU)
- Alpha-2 macroglobulin in the serum (A2MG)
- Alpha-2 macroglobulin in the urine (A2MGU)
- Alprazolam (ALPR)
- Aluminium in the serum (ALU)
- Aluminium in the urine (ALUU)
- Alveolar glomerular basal membrane autoantibodies (ALVBA)
- GBM-antibodies
- Amanitine (AAMAN)
- Amantadine (AMAN)
- Amebiasis (AME)
- Amino acids in the blood (AS)
- Amino acids in the urine (ASU)
- Aminoglycoside antibiotics (AMGL)
- Amiodarone (AMIO)
- Amisulpride (AMISU)
- Ammonia (AMMON)
- Amoeba (AMOE)
- Entamoeba histolytica/dispar
- Amphetamines, methamphetamines, MDA, MDEA, MDMA (AMPH)
- Speed, crystal, meth, ecstasy
- Amylase in the serum (AMY)
- Amylase in urine (AMYL03)
- Amyloid A protein (AMYL04)
- Amyloid beta 1-42 protein (BETA42)
- ANA (ANF) (ANA)
- Antinuclear autoantibodies
- Anaerobic infections (KULAN)
- ANCA, c-, p-, atypical (ANCA)
- anti-neutrophil cytoplasmic antibodies
- Ancylostoma duodenale (ANCY)
- Androstendion (ANDR)